1
|
Wu S, Ye Y, Zhang Q, Kang Q, Xu Z, Ren S, Lin F, Duan Y, Xu H, Hu Z, Yang S, Zhu H, Zou M, Wang Z. Multifunctional Protein Hybrid Nanoplatform for Synergetic Photodynamic-Chemotherapy of Malignant Carcinoma by Homologous Targeting Combined with Oxygen Transport. ADVANCED SCIENCE (WEINHEIM, BADEN-WURTTEMBERG, GERMANY) 2023; 10:e2203742. [PMID: 36541716 PMCID: PMC9929260 DOI: 10.1002/advs.202203742] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/29/2022] [Revised: 11/10/2022] [Indexed: 05/19/2023]
Abstract
Photodynamic therapy (PDT) under hypoxic conditions and drug resistance in chemotherapy are perplexing problems in anti-tumor treatment. In addition, central nervous system neoplasm-targeted nanoplatforms are urgently required. To address these issues, a new multi-functional protein hybrid nanoplatform is designed, consisting of transferrin (TFR) as the multicategory solid tumor recognizer and hemoglobin for oxygen supply (ODP-TH). This protein hybrid framework encapsulates the photosensitizer protoporphyrin IX (PpIX) and chemotherapeutic agent doxorubicin (Dox), which are attached by a glutathione-responsive disulfide bond. Mechanistically, ODP-TH crosses the blood-brain barrier (BBB) and specifically aggregated in hypoxic tumors via protein homology recognition. Oxygen and encapsulated drugs ultimately promote a therapeutic effect by down-regulating the abundance of multidrug resistance gene 1 (MDR1) and hypoxia-inducible factor-1-α (HIF-1α). The results reveal that ODP-TH achieves oxygen transport and protein homology recognition in the hypoxic tumor occupation. Indeed, compared with traditional photodynamic chemotherapy, ODP-TH achieves a more efficient tumor-inhibiting effect. This study not only overcomes the hypoxia-related inhibition in combination therapy by targeted oxygen transport but also achieves an effective treatment of multiple tumors, such as breast cancer and glioma, providing a new concept for the construction of a promising multi-functional targeted and intensive anti-tumor nanoplatform.
Collapse
Affiliation(s)
- Song‐Yu Wu
- State Key Laboratory of Pharmaceutical BiotechnologySchool of Life SciencesInstitute of Artificial Intelligence BiomedicineEngineering Research Center of Protein and Peptide MedicineNanjing UniversityNanjing210023P. R. China
| | - Ya‐Xi Ye
- Institute of Pharmaceutical BiotechnologySchool of Biology and Food EngineeringSuzhou UniversitySuzhou234000P. R. China
| | - Qing Zhang
- State Key Laboratory of Pharmaceutical BiotechnologySchool of Life SciencesInstitute of Artificial Intelligence BiomedicineEngineering Research Center of Protein and Peptide MedicineNanjing UniversityNanjing210023P. R. China
| | - Qian‐Jin Kang
- State Key Laboratory of Pharmaceutical BiotechnologySchool of Life SciencesInstitute of Artificial Intelligence BiomedicineEngineering Research Center of Protein and Peptide MedicineNanjing UniversityNanjing210023P. R. China
| | - Zhu‐Min Xu
- State Key Laboratory of Pharmaceutical BiotechnologySchool of Life SciencesInstitute of Artificial Intelligence BiomedicineEngineering Research Center of Protein and Peptide MedicineNanjing UniversityNanjing210023P. R. China
| | - Shen‐Zhen Ren
- Key Laboratory of Molecular Biophysics Hebei ProvinceInstitute of BiophysicsSchool of SciencesHebei University of TechnologyTianjin300401China
| | - Fan Lin
- Department of PharmacologyDepartment of Cell BiologySchool of Basic Medical SciencesNanjing Medical University101 Longmian Avenue, NanjingJiangning211166China
| | - Yong‐Tao Duan
- Henan provincial key laboratory of children's genetics and metabolic diseasesChildren's Hospital Affiliated to Zhengzhou UniversityZhengzhou UniversityZhengzhou450018China
| | - Hao‐Jun Xu
- Department of PharmacologyDepartment of Cell BiologySchool of Basic Medical SciencesNanjing Medical University101 Longmian Avenue, NanjingJiangning211166China
| | - Zi‐Yi Hu
- Department of PharmacologyDepartment of Cell BiologySchool of Basic Medical SciencesNanjing Medical University101 Longmian Avenue, NanjingJiangning211166China
| | - Sui‐Sui Yang
- Department of PharmacologyDepartment of Cell BiologySchool of Basic Medical SciencesNanjing Medical University101 Longmian Avenue, NanjingJiangning211166China
| | - Hai‐Liang Zhu
- State Key Laboratory of Pharmaceutical BiotechnologySchool of Life SciencesInstitute of Artificial Intelligence BiomedicineEngineering Research Center of Protein and Peptide MedicineNanjing UniversityNanjing210023P. R. China
| | - Mei‐Juan Zou
- Department of PharmacologyDepartment of Cell BiologySchool of Basic Medical SciencesNanjing Medical University101 Longmian Avenue, NanjingJiangning211166China
| | - Zhong‐Chang Wang
- State Key Laboratory of Pharmaceutical BiotechnologySchool of Life SciencesInstitute of Artificial Intelligence BiomedicineEngineering Research Center of Protein and Peptide MedicineNanjing UniversityNanjing210023P. R. China
| |
Collapse
|
2
|
Tan Q, Zhao S, Xu T, Wang Q, Lan M, Yan L, Chen X. Getting drugs to the brain: advances and prospects of organic nanoparticle delivery systems for assisting drugs to cross the blood-brain barrier. J Mater Chem B 2022; 10:9314-9333. [PMID: 36349976 DOI: 10.1039/d2tb01440h] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
The blood-brain barrier (BBB) plays an irreplaceable role in protecting the central nervous system (CNS) from bloodborne pathogens. However, the BBB complicates the treatment of CNS diseases because it prevents almost all therapeutic drugs from getting into the CNS. With the growing understanding of the physiological characteristics of the BBB and the development of nanotechnology, nanomaterial-based drug delivery systems have become promising tools for delivering drugs across the BBB to the CNS. Herein, we systematically summarize the recent progress in organic-nanoparticle delivery systems for treating CNS diseases and evaluate their mechanisms in overcoming the BBB with the aim to provide a comprehensive understanding of the advantages, disadvantages, and challenges of organic nanoparticles in delivering drugs across the BBB. This review may inspire new research ideas and directions for applying nanotechnology to treat CNS diseases.
Collapse
Affiliation(s)
- Qiuxia Tan
- Hunan Provincial Key Laboratory of Micro & Nano Materials Interface Science, College of Chemistry and Chemical Engineering, Central South University, Changsha, 410083, China.
| | - Shaojing Zhao
- Hunan Provincial Key Laboratory of Micro & Nano Materials Interface Science, College of Chemistry and Chemical Engineering, Central South University, Changsha, 410083, China.
| | - Ting Xu
- Hunan Provincial Key Laboratory of Micro & Nano Materials Interface Science, College of Chemistry and Chemical Engineering, Central South University, Changsha, 410083, China.
| | - Qin Wang
- Hunan Provincial Key Laboratory of Micro & Nano Materials Interface Science, College of Chemistry and Chemical Engineering, Central South University, Changsha, 410083, China.
| | - Minhuan Lan
- Hunan Provincial Key Laboratory of Micro & Nano Materials Interface Science, College of Chemistry and Chemical Engineering, Central South University, Changsha, 410083, China.
| | - Li Yan
- College of Health Science and Environmental Engineering, Shenzhen Technology University, Shenzhen, 518118, China.
| | - Xianfeng Chen
- School of Engineering, Institute for Bioengineering, University of Edinburgh, The King's Buildings, Edinburgh EH9 3JL, UK.
| |
Collapse
|
3
|
Tao J, Wei Z, Xu M, Xi L, Cheng Y, Lee SMY, Ge W, Zheng Y. Particle Integrity and Size Effect on the Journey of Polymeric Nanocarriers in Zebrafish Model and the Correlation with Mice. SMALL (WEINHEIM AN DER BERGSTRASSE, GERMANY) 2021; 17:e2103584. [PMID: 34528394 DOI: 10.1002/smll.202103584] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/19/2021] [Revised: 07/15/2021] [Indexed: 05/25/2023]
Abstract
Polymeric nanocarriers have high biocompatibility for potential drug delivery applications. After entering bloodstream, nanocarriers will circulate, interact with proteins, dissociate, or be cleared by reticuloendothelial system. Zebrafish as a visual animal model, can serve as a tool for screening nanomedicines and monitoring nanocarrier behaviors in vivo. However, a comprehensive correlation between zebrafish and rodent models is currently deficient. Here, different-sized poly(caprolactone) nanocarriers (PCL NCs) are fabricated with or without PEGylation to investigate correlation between zebrafish and mice regarding their biofate via Förster resonance energy transfer technique. Results show that PEGylated PCL NCs have higher integrity in both zebrafish and mice. Small PEG-PCL NCs have longer circulation, while large PEG-PCL NCs have dramatically higher macrophage sequestration in zebrafish and mice spleen, leading to poor circulation. PCL NCs dissociate rapidly with less macrophage sequestration. Moreover, in 7 days postfertilization (dpf) zebrafish, polymers are eliminated via hepatobiliary pathway, which is not fully functional at earlier stages of development. The effects of nanocarrier integrity on macrophage sequestration in zebrafish and good correlation with mice spleen are pioneered to be demonstrated. The findings suggest that 7 dpf zebrafish are suitable as an in vivo screening model of nanocarriers and predict their biofate in rodents.
Collapse
Affiliation(s)
- Jinsong Tao
- State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macau, 999078, China
| | - Zhengjie Wei
- State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macau, 999078, China
| | - Meng Xu
- State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macau, 999078, China
| | - Long Xi
- State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macau, 999078, China
| | - Yaxin Cheng
- State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macau, 999078, China
| | - Simon Ming-Yuen Lee
- State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macau, 999078, China
| | - Wei Ge
- Faculty of Health Sciences, University of Macau, Avenida da Universidade, Taipa, Macau, 999078, China
| | - Ying Zheng
- State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macau, 999078, China
| |
Collapse
|
4
|
Jing M, Li Y, Wang M, Zhang H, Wei P, Zhou Y, Ishimwe N, Huang X, Wang L, Wen L, Wang W, Zhang Y. Photoresponsive PAMAM-Assembled Nanocarrier Loaded with Autophagy Inhibitor for Synergistic Cancer Therapy. SMALL (WEINHEIM AN DER BERGSTRASSE, GERMANY) 2021; 17:e2102295. [PMID: 34365730 DOI: 10.1002/smll.202102295] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/19/2021] [Revised: 06/01/2021] [Indexed: 06/13/2023]
Abstract
As one of the most promising drug-delivery carriers due to its small size, easy surface modifiability, and hydrophobic interior, cationic poly(amidoamine) (PAMAM) per se, demonstrated by previous reports and the authors' present study, indicate potential anticancer capability, however, which are restricted by autophagy elicitation. Besides, its side-toxicity profile, having also been extensively documented, limits its translation into the clinic. Herein, the authors design a photoresponsive PAMAM-assembled nanoparticle loaded with the autophagy inhibitor (chloroquine, CQ), which exhibits light responsiveness for precisely controlling drug release and superior dark biosafety. Upon light irradiation, the nanoparticle can dissociate into charged small PAMAM for a significant antitumor effect. Meanwhile, the released CQ can inhibit pro-survival autophagy induced by PAMAM to achieve an excellent synergistic anticancer efficacy in vitro and in vivo. The authors' study provided a vision of utilizing PAMAM as self-carried anticancer therapeutics in combination with an autophagy inhibitor and proposing a cancer therapy with high antitumor efficacy and low side effects to normal tissues.
Collapse
Affiliation(s)
- Manman Jing
- School of Medicine, South China University of Technology, Guangzhou, 510006, China
| | - Yafei Li
- State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Hong Kong, China
- Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
- Dr. Li Dak-Sum Research Centre, The University of Hong Kong, Hong Kong, China
| | - Meimei Wang
- School of Medicine, South China University of Technology, Guangzhou, 510006, China
| | - Hao Zhang
- School of Medicine, South China University of Technology, Guangzhou, 510006, China
| | - Pengfei Wei
- School of Pharmacy, Binzhou Medical University, Yantai, 264003, China
| | - Yang Zhou
- State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Hong Kong, China
- Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
- Dr. Li Dak-Sum Research Centre, The University of Hong Kong, Hong Kong, China
| | - Nestor Ishimwe
- Department of Medicine, Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA, 30912, USA
| | - Xiaowan Huang
- School of Medicine, South China University of Technology, Guangzhou, 510006, China
| | - Liansheng Wang
- Department of Cardiology, Guangdong Provincial People's Hospital & Guangdong Academy of Medical Sciences, Guangzhou, 510080, China
| | - Longping Wen
- School of Medicine, South China University of Technology, Guangzhou, 510006, China
| | - Weiping Wang
- State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Hong Kong, China
- Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
- Dr. Li Dak-Sum Research Centre, The University of Hong Kong, Hong Kong, China
| | - Yunjiao Zhang
- School of Medicine, South China University of Technology, Guangzhou, 510006, China
| |
Collapse
|
5
|
Rong J, He Y, Tang J, Qiao R, Lin S. "Fishing" nano-bio interactions at the key biological barriers. NANOSCALE 2021; 13:5954-5964. [PMID: 33734277 DOI: 10.1039/d1nr00328c] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
Understanding nano-bio interactions is pivotal to the safe implementation of nanotechnology for both biological and environmental applications. Zebrafish as a model organism provides unique opportunities to dissect nano-bio interactions occurring at different biological barriers. In this review, we focus on four key biological barriers, namely cell membrane, blood-brain barrier (BBB), skin and gill epithelia, and gastrointestinal tract (GIT), and highlight recent advancement achieved by using zebrafish to conduct both visualized observations and mechanistic investigations on a diversity of nano-bio interactions.
Collapse
Affiliation(s)
- Jinyu Rong
- College of Environmental Science and Engineering, Biomedical Multidisciplinary Innovation Research Institute, Shanghai East Hospital, Tongji University, Shanghai 200092, China.
| | | | | | | | | |
Collapse
|